Functional Recovery After Medial Monocompartmental Knee Prosthesis: One Day Protocol Versus Fast Protocol
Launched by I.R.C.C.S OSPEDALE GALEAZZI-SANT'AMBROGIO · Mar 4, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different rehabilitation approaches after knee surgery affect recovery for patients with a specific type of knee arthritis called medial monocompartmental gonarthrosis. The trial compares two groups of patients: one group will follow a "one-day protocol" for rehabilitation, while the other group will follow a "fast protocol" during their hospital stay. The goal is to see which method helps patients recover better and faster after their surgery.
To participate in this study, you must be between 40 and 85 years old and diagnosed with a specific level of knee arthritis. You'll also need to be able to understand the study and agree to participate. If you join, you can expect to undergo knee surgery and then follow one of the two rehabilitation plans. This trial is currently looking for participants, and it's important to note that certain conditions, like serious cognitive or psychiatric disorders, may prevent someone from being eligible. Your involvement could help improve recovery methods for future patients with similar knee conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 40\<x\<85 included
- • Medial monocompartmental gonarthrosis grade 3-4 sec Kellgren-Lawrence
- • Primary medial gonarthrosis
- • Signing of the Informed Consent and consent to collaborate in all study procedures.
- Exclusion Criteria:
- • Cognitive decline
- • Psychiatric disorders
- • Neuromuscular disorders
- • Age \> 85 years or \<40
- • Lateral gonarthrosis grade 3-4 sec Kellgren-Lawrence
- • Patella symptoms
- • Secondary medial gonarthrosis
- • Minor age
- • Pregnant women (self-declaration)
About I.R.C.C.S Ospedale Galeazzi Sant'ambrogio
The I.R.C.C.S. Ospedale Galeazzi-Sant'Ambrogio is a leading clinical research institute and hospital in Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As a designated Institute of Hospitalization and Care of Scientific Relevance (I.R.C.C.S.), it focuses on translational research that bridges the gap between laboratory findings and clinical applications. The facility is equipped with state-of-the-art technology and a multidisciplinary team of experts, enabling it to conduct a wide range of clinical trials aimed at improving treatment outcomes across various medical fields. Its dedication to ethical practices and patient safety ensures that all research activities align with the highest international standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milan, Italia, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported